Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 32 Market Cap is ₪21.46 Mil as of Jul. 24, 2026. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 864 Medical Devices & Instruments companies, Erika Carmel-Tech ranks worse than 88.66% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Erika Carmel-Tech's share price for the quarter that ended in Dec. 2025 was ₪0.475. Erika Carmel-Tech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 41.67 Mil. Therefore, Erika Carmel-Tech's market cap for the quarter that ended in Dec. 2025 was ₪19.79 Mil.
Erika Carmel-Tech's quarterly market cap
declined
from Dec. 2024 (₪25.00 Mil) to Jun. 2025 (₪21.15 Mil) and
declined
from Jun. 2025 (₪21.15 Mil) to Dec. 2025 (₪19.79 Mil).
Erika Carmel-Tech's annual market cap
declined
from Dec. 2023 (₪33.33 Mil) to Dec. 2024 (₪25.00 Mil) and
declined
from Dec. 2024 (₪25.00 Mil) to Dec. 2025 (₪19.79 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Erika Carmel-Tech's Enterprise Value for Today is ₪19.86 Mil.
Erika Carmel-Tech (XTAE:ERKA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Erika Carmel-Tech Market Cap Related Terms
Erika Carmel-Tech Market Cap Historical Data
* Premium members only.
The historical data trend for Erika Carmel-Tech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Erika Carmel-Tech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's Market Cap distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Erika Carmel-Tech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Erika Carmel-Tech (XTAE:ERKA) has a Market Cap of ₪21.46 Mil as of Jul. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Erika Carmel-Tech and its competitors. According to the industry distribution chart, Erika Carmel-Tech ranks #766 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 88.7%.
Is Erika Carmel-Tech's Market Cap too high?
Erika Carmel-Tech's current Market Cap is ₪21.46 Mil. Based on the distribution chart, Erika Carmel-Tech ranks #766 out of 864 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #766 out of 864 companies for Market Cap. This places Erika Carmel-Tech in the lower half of its industry. The industry median Market Cap is 116.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.76, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Erika Carmel-Tech and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Erika Carmel-Tech's current Market Cap is ₪21.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current Market Cap is ₪21.46 Mil. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Market Cap is ₪21.46 Mil as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Fairly Valued.
Key valuation signals for XTAE:ERKA:
Market Cap: ₪21.46 Mil
GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score
Get the complete analysis for XTAE:ERKA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
